Correlation Between Passage Bio and Verona Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Passage Bio and Verona Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Passage Bio and Verona Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Passage Bio and Verona Pharma PLC, you can compare the effects of market volatilities on Passage Bio and Verona Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Passage Bio with a short position of Verona Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Passage Bio and Verona Pharma.

Diversification Opportunities for Passage Bio and Verona Pharma

-0.69
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Passage and Verona is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Passage Bio and Verona Pharma PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verona Pharma PLC and Passage Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Passage Bio are associated (or correlated) with Verona Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verona Pharma PLC has no effect on the direction of Passage Bio i.e., Passage Bio and Verona Pharma go up and down completely randomly.

Pair Corralation between Passage Bio and Verona Pharma

Given the investment horizon of 90 days Passage Bio is expected to under-perform the Verona Pharma. In addition to that, Passage Bio is 1.62 times more volatile than Verona Pharma PLC. It trades about -0.18 of its total potential returns per unit of risk. Verona Pharma PLC is currently generating about 0.23 per unit of volatility. If you would invest  3,311  in Verona Pharma PLC on August 27, 2024 and sell it today you would earn a total of  570.00  from holding Verona Pharma PLC or generate 17.22% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Passage Bio  vs.  Verona Pharma PLC

 Performance 
       Timeline  
Passage Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Passage Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Verona Pharma PLC 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Verona Pharma PLC are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Verona Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Passage Bio and Verona Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Passage Bio and Verona Pharma

The main advantage of trading using opposite Passage Bio and Verona Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Passage Bio position performs unexpectedly, Verona Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verona Pharma will offset losses from the drop in Verona Pharma's long position.
The idea behind Passage Bio and Verona Pharma PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Commodity Directory
Find actively traded commodities issued by global exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.